PRNewswire/ -- "According to the latest study from BCC Research, the market for Drug Discovery Technologies is expected to ...

New opioid prescriptions for patients in the UK mostly written for musculoskeletal conditions, in which there is little evidence for opioid efficacy.

Thousands of Australians with osteoporosis will now have access to a game-changing and affordable treatment after the drug ...

A Dexa scan revealed Sarah had osteoporosis and osteopenia in her spine and hips respectively - Matt Writtle ... But I felt ...

The first poster demonstrates proof-of-concept data that Aqtual's therapy selection test can predict treatment response in patients with RA. The second poster provides an interim analysis from ...

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

O rthopedic doctors have a bone to pick with all the people who forget they’re carrying a very important skeleton around ...

Current regulatory guidelines requiring fracture outcomes have curtailed innovation in the treatment of this significant disease due to ethical, time and sizing of studies required to evaluate new ...

This will not only provide new momentum for the overall industry development, but also offer more treatment options ... asthma, osteoporosis, and rare diseases—since its founding in 1980.